Clinical Trials in North Carolina

Showing 6881-6900 of 20,428 trials

Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC)

NCT05136898

This study aims to demonstrate that home instillation of UGN-102 is a feasible alternative to instillation in a clinical setting, which might mitigate patient challenges (logistical, expense, and comfort) when receiving treatment for low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC).

Bladder CancerUrothelial CarcinomaUrothelial Carcinoma Bladder

UroGen Pharma Ltd.8 participantsStarted Nov 2021

Homewood, Alabama, United States • Indianapolis, Indiana, United States • Greensboro, North Carolina, United States +2 more locations

COMPLETEDNA41 miles

(YMP) Young Moms Program

NCT05082857

Young Moms Program (YMP) is designed to address systemic barriers to the health and stability of young moms and their children such as the lack of coordination of service delivery or logistical barriers within the health system. The YMP also streamlines the referral pipeline, connecting moms to evidence-based resources, and ensuring children complete all recommended assessments prior to kindergarten.

Chronic Toxic StressDevelopmental/ Behavioral Regression in Young Children

Wake Forest University Health Sciences15 participantsStarted Dec 2021

Winston-Salem, North Carolina, United States

Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC)

(YMP) Young Moms Program

Find Trials by Condition in North Carolina

ADVANCE- Automated Detection and Volumetric Assessment of ICH

Cereset Research In Healthcare Workers During COVID-19

CPI-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Granulocytic Sarcoma

Study of the P16 Gene as a Predictor of Myelosuppression in Breast Cancer Patients

A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (MK-7962-003/A011-11)(STELLAR)

Tucatinib Combined with Trastuzumab and TAS-102 for the Treatment of HER2 Positive Metastatic Colorectal Cancer in Molecularly Selected Patients, 3T Study

A Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza A

A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine

Efficacy and Safety of MK-1942 When Added to Stable Antidepressant Therapy in Participants With Treatment-Resistant Depression (TRD) (MK-1942-006)

Pharmacokinetics and Pharmacodynamics of Rifaximin Novel Formulations in Patients With Sickle Cell Disease

PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations

Encore PFO Closure Device - The PerFOrm Trial

Umbilical Cord Milking in Non-Vigorous Infants

IMP4297 in Combination With Temozolomide in Patients With Advanced Solid Tumors and Small Cell Lung Cancer

A Randomized Phase 2 Trial of TAS-114 in Combination With S-1 Versus S-1

Study of AZD9291 Plus MEDI4736 Versus AZD9291 Monotherapy in NSCLC After Previous EGFR TKI Therapy in T790M Mutation Positive Tumours

A Trial to Assess Steviol Glycosides on Acute Appetite Hormone Release

Acupuncture for Preterm Infants Requiring Eye-exam